Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Endogenous Reverse Transcriptase Inhibition Attenuates TLR5-Mediated Inflammation

mBio(2023)10.1128/mbio.03280-22Source: DataRank Database

Endogenous Reverse Transcriptase Inhibition Attenuates TLR5-Mediated Inflammation is a research paper published in mBio (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

bioproject

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.70)OA: goldTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Bhavya Singh ORCID,Stephanie Michael ORCID,Morgan M. O’Mara ORCID,Jez L. Marston ORCID,Tongyi Fei ORCID

Live enrichment

PubMed:36645307 PMC:PMC9973353 OpenAlex:https://openalex.org/W4316662920

HHS | NIH | National Cancer Institute

Grant: CA260691

HHS | NIH | National Cancer Institute

Grant: CA206488

NCI NIH HHS

Grant: R01 CA260691

NCI NIH HHS

Grant: R01 CA206488

National Institutes of Health

Grant: 5R01CA260691-02

Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma

National Institutes of Health

Grant: 5R01CA206488-04

HIV induced anti-cancer HERV immunity in prostate, breast and colon cancers

FWCI

2.70

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.03280-22

publisherhttps://doi.org/10.1128/mbio.03280-22

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.03280-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36645307

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9973353

Fields of Study

Chromosomal and Genetic VariationsImmunodeficiency and Autoimmune DisordersRNA and protein synthesis mechanisms0301 basic medicine0303 health sciences03 medical and health sciencesHumansToll-Like Receptor 5RetroelementsRNA-Directed DNA PolymeraseDNA, ComplementaryEndogenous RetrovirusesInflammationAntiviral Agents

MeSH Terms

Antiviral AgentsHumansInflammationRNA-Directed DNA PolymeraseDNA, ComplementaryRetroelementsEndogenous RetrovirusesToll-Like Receptor 5

Keywords

RetrotransposonBiologyEndogenous retrovirusReverse transcriptaseTLR5Proinflammatory cytokineCell biologyInnate immune systemImmune systemGeneticsToll-like receptorTransposable elementRNAGenomeGeneImmunologyInflammationFlagellainnate immunityToll-like Receptors (Tlrs)Long Interspersed Nuclear Element (Line)Human Endogenous Retrovirus (Herv)DNA, ComplementaryRetroelementsEndogenous RetrovirusesObservationRNA-Directed DNA PolymeraseMicrobiologyAntiviral AgentsQR1-502Toll-Like Receptor 5Humans

Sustainable Development Goals

SDG 0: Good health and well-being

Endogenous Reverse Transcriptase Inhibition Attenuates TLR5-Mediated Inflammation

FAIR Checklist

Authors (8)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)